千亿大佬被逼到墙角

CHC医疗传媒
24 Dec 2024

12月20日,诺和诺德公布新一代减重药物CagriSema三期临床试验REDEFINE-1研究的主要结果,该研究历经68周、涉及3417名患者、患者基线体重为106.9公斤,每周接受CagriSema皮下注射患者显示体重减轻22.7%(基于试验产品估算)或20.4%(基于治疗政策估算)。CagriSema是司美格鲁肽与长效Amylin(胰淀素)类似物Cagrilintide组成的一款复方药物,基于...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10